Visit the Scientific Advisors Page. Visit the Management Team Page. Visit the Board of Directors Page. Visit the Scientific Advisors Page.
 

 

Image: PETER JOHANN, PhD

 

PETER JOHANN, PhD

Dr. Johann is a Director of Vivaldi Biosciences Inc. and a member of the Supervisory Board of Vivaldi Biosciences AG. He is a Managing General Partner of NGN Capital. He joined NGN Capital from Boehringer Ingelheim where he was the Division Head of Corporate Development. Dr. Johann has established a worldwide network in the biotech and pharmaceutical industry. His responsibilities at Boehringer Ingelheim included strategic planning, strategic projects, M&A, business development and licensing. He identified and evaluated several licensing, M&A and co-promotion deals. Prior to this Dr. Johann served at F. Hoffmann-La Roche as Global Business Leader where he led global business teams and was responsible for global marketing of oncology products as well as evaluation of pipeline products from internal and external sources. Dr. Johann joined Roche from Boehringer Mannheim where he was Head of Business Development and Marketing Molecular Medicine. Besides marketing activities Dr. Johann was involved in setting up and managing joint venture companies as a member of the supervisory board. He also was responsible for licensing activities in this field. Prior to that position he had Marketing, Sales and Business Development responsibilities at Boehringer Mannheim Biochemicals, among others, for collaborations in the field of biopharmaceuticals. Dr. Johann has additional industry experience in Business Development and Marketing of pharmaceutical products with Kaneka in Japan and industrial enzymes with Röhm in Germany. Dr. Johann obtained his PhD from the Technical University Munich. He currently serves on the Board of Directors of Micromet, Inc., Horizon Pharma, Inc., Resverlogix Corp., Noxxon Pharma AG and Exosome Diagnostics, Inc. He previously served on the Board of Directors of Jerini AG, acquired by Shire Pharmaceuticals, and NaniRx Therapeutics, and as an observer on the board of Santhera Pharmaceuticals AG and Cerapedics, Inc.

   


Website Design and website updates by LoneTree Web Studio, Brentwood, CA

Home | About | Management Team | Board of Directors | Scientific Advisors | Product Development | Publications | Contact